Save after changing Favorites. Use Share Link when you want the same list on another device.
Your link (Favorites):
All Favorites
#
Name
Description
Category
Type
Source
Website
TEN
Germany – Pharmaceutical products – Abschluss einer nicht-exklusiven Rabattvereinbarung nach § 130a Abs. 8 SGB V zum Wirkstoff Teduglutid, ATC A16AX08 für die Zeit 01.06.2026 - 31.05.2028 (zzgl. Verlängerungsoption 1x12 Monate)
Germany – Pharmaceutical products – Abschluss einer nicht-exklusiven Rabattvereinbarung nach § 130a Abs. 8 SGB V zum Wirkstoff Mesalazin (ausschl. Dafo TMR), ATC A07EC02 für die Zeit 01.06.2026 - 31.05.2028 (zzgl. V.-Option 1x12 Mon)
Germany – Pharmaceutical products – Abschluss einer nicht-exklusiven Rabattvereinbarung nach § 130a Abs. 8 SGB V zum Wirkstoff Ganirelix, ATC H01CC01 für die Zeit 01.06.2026 - 31.05.2028 (zzgl. Verlängerungsoption 1x12 Monate)
Germany – Pharmaceutical products – Abschluss einer nicht-exklusiven Rabattvereinbarung nach § 130a Abs. 8 SGB V zum Wirkstoff Piperacillin + Tazobactam, ATC J01CR05 für die Zeit 01.06.2026 - 31.05.2028 (zzgl. V.-Option 1x12 Monate)
Germany – Pharmaceutical products – Abschluss einer nicht-exklusiven Rabattvereinbarung nach § 130a Abs. 8 SGB V zum Wirkstoff Clobazam (ausschl. Dafo TAB), ATC N05BA09 für die Zeit 01.06.2026 - 31.05.2028 (zzgl. V.-Option 1x12 Monate)
Germany – Pharmaceutical products – Abschluss einer nicht-exklusiven Rabattvereinbarung nach § 130a Abs. 8 SGB V zum WS Bimatoprost (ausschl. in der Wirkstärke 0,1mg/ml), ATC S01EE03 f. d. Z. 01.6.26-31.5.28 (zzgl. V.-Option 1x12 Mon)
Germany – Pharmaceutical products – Abschluss einer nicht-exklusiven Rabattvereinbarung nach § 130a Abs. 8 SGB V zum Wirkstoff Dalbavancin, ATC J01XA04 für die Zeit 01.06.2026 - 31.05.2028 (zzgl. Verlängerungsoption 1x12 Monate)
Germany – Pharmaceutical products – Abschluss einer nicht-exklusiven Rabattvereinbarung nach § 130a Abs. 8 SGB V zum Wirkstoff Tianeptin, ATC N06AX14 für die Zeit 01.06.2026 - 31.05.2028 (zzgl. Verlängerungsoption 1x12 Monate)
Germany – Pharmaceutical products – Abschluss einer nicht-exklusiven Rabattvereinbarung nach § 130a Abs. 8 SGB V zum Wirkstoff Pomalidomid, ATC L04AX06 für die Zeit 01.06.2026 - 31.05.2028 (zzgl. Verlängerungsoption 1x12 Monate)
Germany – Pharmaceutical products – Abschluss einer nicht-exklusiven Rabattvereinbarung nach § 130a Abs. 8 SGB V zum Wirkstoff Fondaparinux, ATC B01AX05 für die Zeit 01.06.2026 - 31.05.2028 (zzgl. Verlängerungsoption 1x12 Monate)
Germany – Pharmaceutical products – Abschluss einer nicht-exklusiven Rabattvereinbarung nach § 130a Abs. 8 SGB V zum Wirkstoff Methylprednisolon, ATC D07AC14 für die Zeit 01.06.2026 - 31.05.2028 (zzgl. Verlängerungsoption 1x12 Monate)
Germany – Pharmaceutical products – Abschluss einer nicht-exklusiven Rabattvereinbarung nach § 130a Abs. 8 SGB V zum Wirkstoff Gentamicin, ATC S01AA11 für die Zeit 01.06.2026 - 31.05.2028 (zzgl. Verlängerungsoption 1x12 Monate)
Germany – Pharmaceutical products – Abschluss einer nicht-exklusiven Rabattvereinbarung nach § 130a Abs. 8 SGB V zum Wirkstoff Prednicarbat, ATC D07AC18 für die Zeit 01.06.2026 - 31.05.2028 (zzgl. Verlängerungsoption 1x12 Monate)
Germany – Pharmaceutical products – Abschluss einer nicht-exklusiven Rabattvereinbarung nach § 130a Abs. 8 SGB V zum Wirkstoff Bexaroten, ATC L01XF03 für die Zeit 01.06.2026 - 31.05.2028 (zzgl. Verlängerungsoption 1x12 Monate)
Germany – Pharmaceutical products – Abschluss einer nicht-exklusiven Rabattvereinbarung nach § 130a Abs. 8 SGB V zum Wirkstoff Clobazam (ausschl. Dafo SUE), ATC N05BA09 für die Zeit 01.06.2026 - 31.05.2028 (zzgl. V.-Option 1x12 Monate)
SBIR/STTR Commercialization Readiness Pilot (CRP) Program (Parent SB1 Clinical Trial Optional)
grants.gov
The Commercialization Readiness Pilot (CRP) program helps small business concerns (SBCs) move NIH-funded SBIR or STTR projects from late-stage develop...
GrantCash GrantUnited StatesOpen
AmountNot provided on the source page. Please check the official source.
DeadlineApr 5, 2029
The Commercialization Readiness Pilot (CRP) program helps small business concerns (SBCs) move NIH-funded SBIR or STTR projects from late-stage development to commercialization. The CRP supports later-stage research and development (R&D) and/or technical assistance that Phase II and Phase IIB Strategic Breakthrough awards do not typically support. This includes:Independent replication or confirmation of key studiesIND- or IDE-enabling studiesClinical studiesManufacturing scale-up and related quality activitiesRegulatory and other specialized technical supportSBCs may subcontract (outsource) a significant amount of the work in a CRP to meet the project goals.
GRA
NIH Small Business Innovation Research (SBIR) Phase IIB Strategic Breakthrough Award (Parent [R44] Clinical Trial Optional)
grants.gov
The NIH Phase IIB Strategic Breakthrough award bridges the funding gap between the end of a Small Business Innovation Research (SBIR) and Small Busine...
GrantCash GrantUnited StatesOpen
AmountNot provided on the source page. Please check the official source.
DeadlineApr 5, 2029
The NIH Phase IIB Strategic Breakthrough award bridges the funding gap between the end of a Small Business Innovation Research (SBIR) and Small Business Technology Transfer (STTR) Phase II award and commercialization. The Phase IIB Strategic Breakthrough provides previously funded NIH SBIR or STTR projects additional support for later-stage research and development (R&D).
TEN
France – Technical computer support services – Prestation de maîtrise d'uvre - Expert Talend / BI
ted.europa.eu
Buyer: Institut d’émission des départements d’outre-mer (IEDOM) | Notice type: cn-standard | Procedure: open | Contract: services | Deadline: 2029-04-...
TenderProcurement ContractFranceOpen
AmountNot provided on the source page. Please check the official source.
DeadlineApr 6, 2029
Buyer: Institut d’émission des départements d’outre-mer (IEDOM) | Notice type: cn-standard | Procedure: open | Contract: services | Deadline: 2029-04-06
TEN
Sweden – Non-medical equipment based on the use of radiations – Röntgenutrustning
Predoctoral to Postdoctoral Transition Award (Parent F99/K00 - Clinical Trial Not Allowed)
grants.gov
The purpose of this award is to support promising graduate students as they complete their doctoral research training and transition into mentored pos...
GrantCash GrantUnited StatesOpen
AmountNot provided on the source page. Please check the official source.
DeadlineApr 8, 2029
The purpose of this award is to support promising graduate students as they complete their doctoral research training and transition into mentored postdoctoral career development opportunities in research areas relevant to the missions of participating NIH Institutes and Centers.This Notice of Funding Opportunity (NOFO) does not allow candidates to propose to lead an independent clinical trial, but does allow candidates to propose research experience in a clinical trial led by a sponsor or co-sponsor.
TEN
Bulgaria – Disinfectants – Динамична система за покупки на дезинфектанти и консумативи за стерилизация за нуждите на „СБАЛАГ - Майчин дом" ЕАД за период от 48 месеца
ted.europa.eu
Buyer: Специализирана болница за активно лечение по акушерство и гинекология - Майчин дом ЕАД | Notice type: cn-standard | Procedure: restricted | Con...
TenderProcurement ContractBulgariaOpen
AmountNot provided on the source page. Please check the official source.
DeadlineApr 9, 2029
Buyer: Специализирана болница за активно лечение по акушерство и гинекология - Майчин дом ЕАД | Notice type: cn-standard | Procedure: restricted | Contract: supplies | Deadline: 2029-04-09
No saved opportunities on this page
Use the star icon near an opportunity title to add it to Favorites.
📅 Best viewed on desktop - or rotate your phone to landscape mode.
#
Opportunity
Type
Region / Country
Amount
Deadline
Source
42601
Germany – Pharmaceutical products – Abschluss einer nicht-exklusiven Rabattvereinbarung nach § 130a Abs. 8 SGB V zum Wirkstoff Teduglutid, ATC A16AX08 für die Zeit 01.06.2026 - 31.05.2028 (zzgl. Verlängerungsoption 1x12 Monate)Buyer: DAK-Gesundheit | Notice type: cn-standard | Procedure: open | Contract: supplies | Deadline: 2029-04-05
Tender
Procurement Contract
Germany
Not provided on the source page. Please check the official source.
Germany – Pharmaceutical products – Abschluss einer nicht-exklusiven Rabattvereinbarung nach § 130a Abs. 8 SGB V zum WS Bimatoprost (ausschl. in der Wirkstärke 0,1mg/ml), ATC S01EE03 f. d. Z. 01.6.26-31.5.28 (zzgl. V.-Option 1x12 Mon)Buyer: DAK-Gesundheit | Notice type: cn-standard | Procedure: open | Contract: supplies | Deadline: 2029-04-05
Tender
Procurement Contract
Germany
Not provided on the source page. Please check the official source.
SBIR/STTR Commercialization Readiness Pilot (CRP) Program (Parent SB1 Clinical Trial Optional)The Commercialization Readiness Pilot (CRP) program helps small business concerns (SBCs) move NIH-funded SBIR or STTR projects fro...
Grant
Cash Grant
United States
Not provided on the source page. Please check the official source.
The Commercialization Readiness Pilot (CRP) program helps small business concerns (SBCs) move NIH-funded SBIR or STTR projects from late-stage development to commercialization. The CRP supports later-stage research and development (R&D) and/or technical assistance that Phase II and Phase IIB Strategic Breakthrough awards do not typically support. This includes:Independent replication or confirmation of key studiesIND- or IDE-enabling studiesClinical studiesManufacturing scale-up and related quality activitiesRegulatory and other specialized technical supportSBCs may subcontract (outsource) a significant amount of the work in a CRP to meet the project goals.
42621
NIH Small Business Innovation Research (SBIR) Phase IIB Strategic Breakthrough Award (Parent [R44] Clinical Trial Optional)The NIH Phase IIB Strategic Breakthrough award bridges the funding gap between the end of a Small Business Innovation Research (SB...
Grant
Cash Grant
United States
Not provided on the source page. Please check the official source.
The NIH Phase IIB Strategic Breakthrough award bridges the funding gap between the end of a Small Business Innovation Research (SBIR) and Small Business Technology Transfer (STTR) Phase II award and commercialization. The Phase IIB Strategic Breakthrough provides previously funded NIH SBIR or STTR projects additional support for later-stage research and development (R&D).
42622
France – Technical computer support services – Prestation de maîtrise d'uvre - Expert Talend / BIBuyer: Institut d’émission des départements d’outre-mer (IEDOM) | Notice type: cn-standard | Procedure: open | Contract: services...
Tender
Procurement Contract
France
Not provided on the source page. Please check the official source.
Buyer: Institut d’émission des départements d’outre-mer (IEDOM) | Notice type: cn-standard | Procedure: open | Contract: services | Deadline: 2029-04-06
42623
Sweden – Non-medical equipment based on the use of radiations – RöntgenutrustningBuyer: Tullverket | Notice type: cn-standard | Procedure: restricted | Contract: supplies | Deadline: 2029-04-07
Tender
Procurement Contract
Sweden
Not provided on the source page. Please check the official source.
Predoctoral to Postdoctoral Transition Award (Parent F99/K00 - Clinical Trial Not Allowed)The purpose of this award is to support promising graduate students as they complete their doctoral research training and transiti...
Grant
Cash Grant
United States
Not provided on the source page. Please check the official source.
The purpose of this award is to support promising graduate students as they complete their doctoral research training and transition into mentored postdoctoral career development opportunities in research areas relevant to the missions of participating NIH Institutes and Centers.This Notice of Funding Opportunity (NOFO) does not allow candidates to propose to lead an independent clinical trial, but does allow candidates to propose research experience in a clinical trial led by a sponsor or co-sponsor.
42625
Bulgaria – Disinfectants – Динамична система за покупки на дезинфектанти и консумативи за стерилизация за нуждите на „СБАЛАГ - Майчин дом" ЕАД за период от 48 месецаBuyer: Специализирана болница за активно лечение по акушерство и гинекология - Майчин дом ЕАД | Notice type: cn-standard | Procedu...
Tender
Procurement Contract
Bulgaria
Not provided on the source page. Please check the official source.
